194 related articles for article (PubMed ID: 1373381)
21. DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase.
Boeck AT; Schopfer LM; Lockridge O
Biochem Pharmacol; 2002 Jun; 63(12):2101-10. PubMed ID: 12110369
[TBL] [Abstract][Full Text] [Related]
22. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase.
Biberoglu K; Tacal Ö; Akbulut H
Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486
[TBL] [Abstract][Full Text] [Related]
23. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants.
Schwarz M; Loewenstein-Lichtenstein Y; Glick D; Liao J; Norgaard-Pedersen B; Soreq H
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):101-10. PubMed ID: 7476018
[TBL] [Abstract][Full Text] [Related]
24. Mutations and impaired expression in the ACHE and BCHE genes: neurological implications.
Soreq H; Ehrlich G; Schwarz M; Loewenstein Y; Glick D; Zakut H
Biomed Pharmacother; 1994; 48(5-6):253-9. PubMed ID: 7999987
[TBL] [Abstract][Full Text] [Related]
25. Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
Xue L; Hou S; Yang W; Fang L; Zheng F; Zhan CG
Chem Biol Interact; 2013 Mar; 203(1):57-62. PubMed ID: 22917637
[TBL] [Abstract][Full Text] [Related]
26. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Nachon F; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2008 Mar; 18(3):213-8. PubMed ID: 18300943
[TBL] [Abstract][Full Text] [Related]
27. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
28. Plant-expressed cocaine hydrolase variants of butyrylcholinesterase exhibit altered allosteric effects of cholinesterase activity and increased inhibitor sensitivity.
Larrimore KE; Kazan IC; Kannan L; Kendle RP; Jamal T; Barcus M; Bolia A; Brimijoin S; Zhan CG; Ozkan SB; Mor TS
Sci Rep; 2017 Sep; 7(1):10419. PubMed ID: 28874829
[TBL] [Abstract][Full Text] [Related]
29. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity.
Vellom DC; Radić Z; Li Y; Pickering NA; Camp S; Taylor P
Biochemistry; 1993 Jan; 32(1):12-7. PubMed ID: 8418833
[TBL] [Abstract][Full Text] [Related]
30. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284
[TBL] [Abstract][Full Text] [Related]
31. Screening assays for cholinesterases resistant to inhibition by organophosphorus toxicants.
Wang Y; Schopfer LM; Duysen EG; Nachon F; Masson P; Lockridge O
Anal Biochem; 2004 Jun; 329(1):131-8. PubMed ID: 15136175
[TBL] [Abstract][Full Text] [Related]
32. Resistance of butyrylcholinesterase to inactivation by ultrasound: effects of ultrasound on catalytic activity and subunit association.
Froment MT; Lockridge O; Masson P
Biochim Biophys Acta; 1998 Sep; 1387(1-2):53-64. PubMed ID: 9748500
[TBL] [Abstract][Full Text] [Related]
33. Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.
Zheng F; Yang W; Xue L; Hou S; Liu J; Zhan CG
Biochemistry; 2010 Oct; 49(42):9113-9. PubMed ID: 20886866
[TBL] [Abstract][Full Text] [Related]
34. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization.
Nachon F; Nicolet Y; Viguié N; Masson P; Fontecilla-Camps JC; Lockridge O
Eur J Biochem; 2002 Jan; 269(2):630-7. PubMed ID: 11856322
[TBL] [Abstract][Full Text] [Related]
35. Expression of cholinesterase gene(s) in human brain tissues: translational evidence for multiple mRNA species.
Soreq H; Zevin-Sonkin D; Razon N
EMBO J; 1984 Jun; 3(6):1371-5. PubMed ID: 6745236
[TBL] [Abstract][Full Text] [Related]
36. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
37. Determination of binding points of methylene blue and cationic phenoxazine dyes on human butyrylcholinesterase.
Sezgin Z; Biberoglu K; Chupakhin V; Makhaeva GF; Tacal O
Arch Biochem Biophys; 2013 Apr; 532(1):32-8. PubMed ID: 23353050
[TBL] [Abstract][Full Text] [Related]
38. Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding.
Shafferman A; Kronman C; Flashner Y; Leitner M; Grosfeld H; Ordentlich A; Gozes Y; Cohen S; Ariel N; Barak D
J Biol Chem; 1992 Sep; 267(25):17640-8. PubMed ID: 1517212
[TBL] [Abstract][Full Text] [Related]
39. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2007 Sep; 17(9):681-5. PubMed ID: 17700357
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
